Impact of antithrombin III on hepatic and intestinal microcirculation in experimental liver cirrhosis and bowel inflammation: An in vivo analysis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 32

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

223

HTML

2163

Tables (1-4)

197

Sum=2583

Aug 28, 2005 (publication date) through Dec 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Aug 28, 2005; 11(32): 4997-5001
Published online Aug 28, 2005. doi: 10.3748/wjg.v11.i32.4997

Table 1 Cardiorespiratory parameters at the beginning of intravital videomicroscopy (mean±SD)

	Cirrhosis	Cirrhosis and IBD	ATIII treatment group(cirrhosis and IBD)	Controls
Mean arterial blood	107±8.4	102±8.7	106±7.8	112±7.3
pressure (mmHg)
Heart rate (bpm)	310±9.2	318±7.4	312±8.2	304±8.4
paO₂ (mmHg)	89.1±5.3	86.4±4.3	88.6±5.4	92.3±4.8

Citation: Maksan SM, Ülger Z, Gebhard MM, Schmidt J. Impact of antithrombin III on hepatic and intestinal microcirculation in experimental liver cirrhosis and bowel inflammation: An in vivo analysis. World J Gastroenterol 2005; 11(32): 4997-5001
URL: https://www.wjgnet.com/1007-9327/full/v11/i32/4997.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i32.4997